207 related articles for article (PubMed ID: 34170054)
1. Activation of trace amine-associated receptor 1 attenuates nicotine withdrawal-related effects.
Wu R; Liu J; Johnson B; Huang Y; Zhang Y; Li JX
Addict Biol; 2022 Jan; 27(1):e13075. PubMed ID: 34170054
[TBL] [Abstract][Full Text] [Related]
2. Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats.
Cohen A; Treweek J; Edwards S; Leão RM; Schulteis G; Koob GF; George O
Addict Biol; 2015 Jan; 20(1):56-68. PubMed ID: 23869743
[TBL] [Abstract][Full Text] [Related]
3. A partial trace amine-associated receptor 1 agonist exhibits properties consistent with a methamphetamine substitution treatment.
Pei Y; Asif-Malik A; Hoener M; Canales JJ
Addict Biol; 2017 Sep; 22(5):1246-1256. PubMed ID: 27193165
[TBL] [Abstract][Full Text] [Related]
4. Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds.
Pei Y; Mortas P; Hoener MC; Canales JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():70-5. PubMed ID: 26048337
[TBL] [Abstract][Full Text] [Related]
5. The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.
Yuan M; Malagon AM; Yasuda D; Belluzzi JD; Leslie FM; Zaveri NT
Behav Brain Res; 2017 Aug; 333():251-257. PubMed ID: 28693859
[TBL] [Abstract][Full Text] [Related]
6. Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects.
Liu JF; Seaman R; Siemian JN; Bhimani R; Johnson B; Zhang Y; Zhu Q; Hoener MC; Park J; Dietz DM; Li JX
Neuropsychopharmacology; 2018 Nov; 43(12):2435-2444. PubMed ID: 29472642
[TBL] [Abstract][Full Text] [Related]
7. Effects of a trace amine-associated receptor 1 agonist RO 5263397 on ethanol-induced behavioral sensitization.
Wu R; Liu J; Wang K; Huang Y; Zhang Y; Li JX
Behav Brain Res; 2020 Jul; 390():112641. PubMed ID: 32407821
[TBL] [Abstract][Full Text] [Related]
8. Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine.
Sukhanov I; Dorofeikova M; Dolgorukova A; Dorotenko A; Gainetdinov RR
Front Pharmacol; 2018; 9():329. PubMed ID: 29681856
[TBL] [Abstract][Full Text] [Related]
9. Activation of trace amine-associated receptor 1 attenuates schedule-induced polydipsia in rats.
Sukhanov I; Dorotenko A; Dolgorukova A; Hoener MC; Gainetdinov RR; Bespalov AY
Neuropharmacology; 2019 Jan; 144():184-192. PubMed ID: 30366004
[TBL] [Abstract][Full Text] [Related]
10. TAAR1 agonists attenuate extended-access cocaine self-administration and yohimbine-induced reinstatement of cocaine-seeking.
Liu J; Johnson B; Wu R; Seaman R; Vu J; Zhu Q; Zhang Y; Li JX
Br J Pharmacol; 2020 Aug; 177(15):3403-3414. PubMed ID: 32246467
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms.
Hamouda AK; Bautista MR; Akinola LS; Alkhlaif Y; Jackson A; Carper M; Toma WB; Garai S; Chen YC; Thakur GA; Fowler CD; Damaj MI
Neuropharmacology; 2021 Jun; 190():108568. PubMed ID: 33878302
[TBL] [Abstract][Full Text] [Related]
12. Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.
Bruijnzeel AW; Bishnoi M; van Tuijl IA; Keijzers KF; Yavarovich KR; Pasek TM; Ford J; Alexander JC; Yamada H
Psychopharmacology (Berl); 2010 Dec; 212(4):485-99. PubMed ID: 20697697
[TBL] [Abstract][Full Text] [Related]
13. Activation of trace amine-associated receptor 1 selectively attenuates the reinforcing effects of morphine.
Liu J; Seaman R; Johnson B; Wu R; Vu J; Tian J; Zhang Y; Li JX
Br J Pharmacol; 2021 Feb; 178(4):933-945. PubMed ID: 33247948
[TBL] [Abstract][Full Text] [Related]
14. CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats.
George O; Ghozland S; Azar MR; Cottone P; Zorrilla EP; Parsons LH; O'Dell LE; Richardson HN; Koob GF
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17198-203. PubMed ID: 17921249
[TBL] [Abstract][Full Text] [Related]
15. Activation of PPARγ Attenuates the Expression of Physical and Affective Nicotine Withdrawal Symptoms through Mechanisms Involving Amygdala and Hippocampus Neurotransmission.
Domi E; Caputi FF; Romualdi P; Domi A; Scuppa G; Candeletti S; Atkins A; Heilig M; Demopulos G; Gaitanaris G; Ciccocioppo R; Ubaldi M
J Neurosci; 2019 Dec; 39(49):9864-9875. PubMed ID: 31685649
[TBL] [Abstract][Full Text] [Related]
16. Activation of Peripheral κ-Opioid Receptors Normalizes Caffeine Effects Modified in Nicotine-Dependent Rats during Nicotine Withdrawal.
Sudakov SK; Bogdanova NG
Bull Exp Biol Med; 2016 Oct; 161(6):743-745. PubMed ID: 27785643
[TBL] [Abstract][Full Text] [Related]
17. GABA
Varani AP; Pedrón VT; Aon AJ; Canero EM; Balerio GN
Biomed Pharmacother; 2021 Aug; 140():111786. PubMed ID: 34144406
[TBL] [Abstract][Full Text] [Related]
18. The Action of TAAR1 Agonist RO5263397 on Executive Functions in Rats.
Dorotenko A; Tur M; Dolgorukova A; Bortnikov N; Belozertseva IV; Zvartau EE; Gainetdinov RR; Sukhanov I
Cell Mol Neurobiol; 2020 Mar; 40(2):215-228. PubMed ID: 31734895
[TBL] [Abstract][Full Text] [Related]
19. The "stop" and "go" of nicotine dependence: role of GABA and glutamate.
D'Souza MS; Markou A
Cold Spring Harb Perspect Med; 2013 Jun; 3(6):. PubMed ID: 23732855
[TBL] [Abstract][Full Text] [Related]
20. Sustained AAV-mediated overexpression of CRF in the central amygdala diminishes the depressive-like state associated with nicotine withdrawal.
Qi X; Shan Z; Ji Y; Guerra V; Alexander JC; Ormerod BK; Bruijnzeel AW
Transl Psychiatry; 2014 Apr; 4(4):e385. PubMed ID: 24755994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
